Literature DB >> 31486735

Gene polymorphisms in VEGFA and COL2A1 are associated with response to inhaled corticosteroids in children with asthma.

Zan Wan1,2, Yongjun Tang1,3, Qianqian Song1,2, Jun Zhang4, Wanying Xie1,2, Yijing He1,2, Rong Huang3, Xiangrong Zheng3, Chentao Liu3, Jie Liu1,2,5,6.   

Abstract

Aim: The purpose of this study was to investigate the involvement of single-nucleotide polymorphisms in VEGFA, TBX21 and COL2A1 in the response to inhaled corticosteroids in asthmatic children. Subjects & methods: Children with mild-to-moderate asthma were enrolled in the study. The SEQUENOM MassARRAY method was used to sequence 27 SNP genotypes. By ranking the data from smallest to largest, we could infer whether the change in distribution of forced expiratory volume in one second/forced vital capcacity (FEV1/FVC) and fractional exhaled nitric oxide differed between genotype groups.
Results: VEGFA rs3025039 T allele carriers had a smaller change in FEV1 than CC carriers (p = 0.040), and in COL2A1 rs3809324, the frequency of T allele carriers was lower than that of GG carriers (p = 0.048). rs3025039 was also associated with changes in FEV1/FVC (p = 0.016).
Conclusion: VEGFA and COL2A1 polymorphisms are significantly associated with the response to inhaled corticosteroids in asthmatic children.

Entities:  

Keywords:  asthma; inhaled corticosteroid; single nucleotide polymorphisms

Mesh:

Substances:

Year:  2019        PMID: 31486735     DOI: 10.2217/pgs-2019-0036

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  4 in total

1.  Correlation Meta-Analysis of the Efficacy of Inhaled Corticosteroids in Children with Asthma Based on Smart Medical Health.

Authors:  Yu Qin; Jing Wang; Jingmin Qin; Ning Yang; Sha Li; Lijia Xu; Yanjun Han
Journal:  J Healthc Eng       Date:  2022-04-13       Impact factor: 3.822

2.  Analysis of the Mechanism of Zhichuanling Oral Liquid in Treating Bronchial Asthma Based on Network Pharmacology.

Authors:  Ruiyin Wang; Jiangtao Lin
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-17       Impact factor: 2.629

3.  Network Pharmacology Strategy to Investigate the Pharmacological Mechanism of HuangQiXiXin Decoction on Cough Variant Asthma and Evidence-Based Medicine Approach Validation.

Authors:  Qingqing Xia; Mingtao Liu; Hui Li; Lijun Tian; Jia Qi; Yufeng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-30       Impact factor: 2.629

Review 4.  Pharmacogenomics: A Step forward Precision Medicine in Childhood Asthma.

Authors:  Giuliana Ferrante; Salvatore Fasola; Velia Malizia; Amelia Licari; Giovanna Cilluffo; Giorgio Piacentini; Stefania La Grutta
Journal:  Genes (Basel)       Date:  2022-03-28       Impact factor: 4.141

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.